Meta’s VR know-how helps to coach surgeons and deal with sufferers

Meta CEO Mark Zuckerberg demonstrates an Oculus Rift virtual reality (VR) headset and Oculus Touch controllers during the Oculus Connect 3 event in San Jose, California, U.S., on Thursday, Oct. 6, 2016. David Paul Morris | Bloomberg | Getty Images Just days before assisting in his first major shoulder-replacement surgery last year, Dr. Jake Shine …

Moderna says new Covid vaccine efficient towards BA.2.86 variant

Artur Widak | Nurphoto | Getty Images Moderna‘s new Covid vaccine produced a strong immune response against BA.2.86, a highly mutated omicron variant that health officials are watching closely, according to clinical trial data the biotech company released Wednesday.  The updated shot produced an 8.7-fold increase in protective antibodies against BA.2.86, which has been detected …

Decide withdraws from Medicare drug worth case after inventory possession is revealed

Ohio Governor Mike DeWine, right, shakes hands with Judge Thomas Rose of the U.S. District Court Southern District of Ohio after taking his oath of office, Monday, Jan. 14, 2019, in Cedarville, Ohio. John Minchillo | AP A federal judge on Friday withdrew from a case that could block Medicare from negotiating over drug prices, …

Listed below are the Eight trades and three price-target modifications we made throughout a busy week

Our portfolio experienced a flurry of adjustments in a week dominated by Nvidia’s (NVDA) quarterly results Wednesday evening and Federal Reserve Chairman Jerome Powell’s Jackson Hole address Friday. Here’s a day-by-day look at the trades and price-target changes, and what motivated each decision. Monday Monday proved to be a harbinger for the rest of the …

CVS Well being, Sandoz companion on low cost Humira biosimilar

Rafael Henrique | Lightrocket | Getty Images CVS Health is partnering with drugmaker Sandoz to produce a near identical version of the blockbuster arthritis treatment Humira that will sell for 80% below the price of the brand-named drug. The move is part of the company’s new venture focused on securing, and in some cases co-producing, …

New vaccines will possible defend in opposition to Eris variant

A pharmacist prepares to administer Covid-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center in Chicago, Illinois, Sept. 9, 2022. Scott Olson | Getty Images New Covid vaccines from Pfizer, Moderna and Novavax will likely provide protection against the new “Eris” variant, now the …

Jim Cramer talks about his ‘favourite inventory,’ telling buyers to purchase some

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks rose Monday, though they’re still having a rough August. Nvidia (NVDA), which has been slumping recently, jumped about 5.5% to start the week. Morgan Stanley reiterated Nvidia …

Wegovy-maker Novo Nordisk extends curb on provide of weight-loss drug, raises outlook

A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023.  Jim Vondruska | Reuters Novo Nordisk, which makes blockbuster drug Wegovy, raised its outlook for 2023 Thursday but said it is extending supply restrictions for some doses of the weight-loss drug. The Danish pharmaceutical …

Listed below are the 5 price-target modifications and Four trades we made throughout this busy earnings week

In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for some of our biggest stocks. Many of these moves stemmed from what we saw in quarterly numbers and heard on conference calls. Here’s a day-by-day look at the portfolio action. Monday The week began with our decision to exit …

Pfizer (PFE) Q2 earnings report 2023

Pavlo Gonchar | Lightrocket | Getty Images Pfizer on Tuesday reported second-quarter adjusted earnings that topped Wall Street’s expectations, but posted revenue that fell short of estimates as Covid product sales plunged. Pfizer reported second-quarter sales of $12.73 billion, down 54% over the same period a year ago. Excluding sales of the company’s Covid vaccine …